Annual Working Capital
$21.00 M
-$17.04 M-44.80%
31 December 2023
Summary:
Cardiol Therapeutics annual working capital is currently $21.00 million, with the most recent change of -$17.04 million (-44.80%) on 31 December 2023. During the last 3 years, it has risen by +$11.25 million (+115.40%). CRDL annual working capital is now -64.57% below its all-time high of $59.27 million, reached on 31 December 2021.CRDL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$7.64 M
-$3.36 M-30.54%
30 September 2024
Summary:
Cardiol Therapeutics quarterly working capital is currently $7.64 million, with the most recent change of -$3.36 million (-30.54%) on 30 September 2024. Over the past year, it has dropped by -$17.68 million (-69.81%). CRDL quarterly working capital is now -87.10% below its all-time high of $59.27 million, reached on 01 December 2021.CRDL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.8% | -69.8% |
| 3 y3 years | +115.4% | -65.6% |
| 5 y5 years | +30.7% | -35.5% |
CRDL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.6% | +115.4% | -87.1% | at low |
| 5 y | 5 years | -64.6% | +115.4% | -87.1% | at low |
| alltime | all time | -64.6% | +1044.1% | -87.1% | +316.4% |
Cardiol Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.64 M(-30.5%) |
| June 2024 | - | $11.00 M(-24.6%) |
| Mar 2024 | - | $14.59 M(-30.5%) |
| Dec 2023 | $21.00 M(-44.8%) | $21.00 M(-17.1%) |
| Sept 2023 | - | $25.32 M(-12.2%) |
| June 2023 | - | $28.85 M(-13.3%) |
| Mar 2023 | - | $33.26 M(-12.6%) |
| Dec 2022 | $38.04 M(-35.8%) | $38.04 M(-10.5%) |
| Sept 2022 | - | $42.49 M(-12.0%) |
| June 2022 | - | $48.31 M(-12.0%) |
| Mar 2022 | - | $54.93 M(-7.3%) |
| Dec 2021 | $59.27 M | - |
| Dec 2021 | - | $59.27 M(+166.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $22.24 M(-16.4%) |
| June 2021 | - | $26.61 M(+92.5%) |
| Mar 2021 | - | $13.82 M(+41.8%) |
| Dec 2020 | $9.75 M(-6.9%) | $9.75 M(-39.6%) |
| Sept 2020 | - | $16.14 M(-12.5%) |
| June 2020 | - | $18.44 M(+126.2%) |
| Mar 2020 | - | $8.15 M(-22.1%) |
| Dec 2019 | $10.47 M(-34.8%) | $10.47 M(-11.6%) |
| Sept 2019 | - | $11.85 M(-17.4%) |
| June 2019 | - | $14.34 M(-10.1%) |
| Mar 2019 | - | $15.95 M(-0.7%) |
| Dec 2018 | $16.07 M(+775.4%) | $16.07 M(+138.8%) |
| Sept 2018 | - | $6.73 M(+266.5%) |
| Dec 2017 | $1.84 M | $1.84 M |
FAQ
- What is Cardiol Therapeutics annual working capital?
- What is the all time high annual working capital for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual working capital year-on-year change?
- What is Cardiol Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly working capital year-on-year change?
What is Cardiol Therapeutics annual working capital?
The current annual working capital of CRDL is $21.00 M
What is the all time high annual working capital for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual working capital is $59.27 M
What is Cardiol Therapeutics annual working capital year-on-year change?
Over the past year, CRDL annual working capital has changed by -$17.04 M (-44.80%)
What is Cardiol Therapeutics quarterly working capital?
The current quarterly working capital of CRDL is $7.64 M
What is the all time high quarterly working capital for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly working capital is $59.27 M
What is Cardiol Therapeutics quarterly working capital year-on-year change?
Over the past year, CRDL quarterly working capital has changed by -$17.68 M (-69.81%)